Physician profile
James Mckenzie
NPI 1063807196
$8,639.69
in general payments reported to CMS, 2019-2025
10 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,120 · 2020: $394 · 2021: $1,528 · 2022: $310 · 2023: $748 · 2024: $363 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012 · Travel and Lodging: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.56 |
| Travel and Lodging | $276.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $5,120.00 | 2019 | |
| Stryker Corporation | $1,226.56 | 2020-2025 | Everest Spinal System, Tritanium, Xia 3 |
| Medtronic, INC. | $1,115.68 | 2021-2024 | Mazor X System, Intellis Adaptivestim, Infinity Occipitocervical Upper Thoracic System |
| Nuvasive, INC. | $403.76 | 2020-2021 | |
| Abbott Laboratories | $315.12 | 2022-2023 | Penta |
| Carbofix Orthopedics INC | $114.02 | 2025 | |
| Medtronic USA, INC. | $111.52 | 2020 | |
| Depuy Synthes Sales INC. | $97.77 | 2021 | |
| Cerapedics INC. | $77.10 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Orthofix Medical, INC. | $58.16 | 2022-2023 | Spinal-Stim, Spinal-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.